TCF.L

Theracryf Plc TCF.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TCF.L CRTX.L FUM.L FDBK.L POLX.L CIZ.L ROQ.L NFX.L N4P.L AGL.L
6M -8.89 % 7.24 % -76.16 % -35.38 % -55.00 % -8.06 % 20.43 % 113.96 % 51.88 % -78.13 %
YTD -60.95 % -2.97 % -93.16 % -44.00 % -66.17 % -10.94 % -46.95 % 467.00 % 8.49 % -84.78 %
1Y -71.72 % 7.24 % -93.55 % -81.25 % -66.67 % -26.92 % -42.87 % 353.60 % -5.08 % -77.42 %
3Y -95.64 % -96.05 % -94.65 % -89.66 % -98.97 % -9.52 % -70.78 % -20.14 % -81.02 % -96.63 %
5Y -98.44 % -97.41 % -85.17 % -94.75 % -99.30 % -84.80 % -66.99 % -90.85 % -91.37 % -96.58 %
10Y -99.41 % -100.00 % -91.68 % -98.07 % -96.70 % -84.80 % -66.99 % -89.20 % -81.63 % -97.86 %
From the beginning -99.41 % -100.00 % -96.98 % -99.93 % -96.70 % -84.80 % -66.99 % -89.20 % -99.96 % -98.83 %

Dividend

CRISM Therapeutics Corporation

Feedback plc

N4 Pharma Plc